The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Patient experience and attitudes toward addressing the cost of breast cancer care.
Blair Billings Irwin
No relevant relationships to disclose
Yousuf Zafar
No relevant relationships to disclose
Ivy Altomare
No relevant relationships to disclose
Gretchen Genevieve Kimmick
Honoraria - CHAMBER Foundation
Research Funding - Bionovo; Bristol-Myers Squibb; GlaxoSmithKline; Wyeth
Other Remuneration - AstraZeneca; Genomic Health; Novartis; Pfizer
P. Kelly Marcom
No relevant relationships to disclose
Kevin Houck
No relevant relationships to disclose
Jeffrey M. Peppercorn
Employment or Leadership Position - GlaxoSmithKline (I)
Consultant or Advisory Role - Bayer; Genentech
Stock Ownership - GlaxoSmithKline (I)